Monoclonal antibodies against porcine platelet membrane glycoproteins Ib
and IIb/IIIa
H Takami, WL Nichols, SE Kaese, RS Miller, JA Katzmann and EJ Bowie
Section of Hematology Research, Mayo Clinic/Foundation, Rochester, MN
55905.
We prepared murine monoclonal antibodies to porcine platelet membrane
glycoprotein (GP) Ib and GP IIb/IIIa for further study of the porcine
hemostatic mechanism. One monoclonal antibody, designated PP3-4C, blocked
Ristocetin-induced platelet agglutination and caused 80% inhibition of
Ristocetin-induced 125I-von Willebrand factor (vWF) binding to porcine
platelets at a concentration of greater than or equal to 12 micrograms
IgG/mL. PP3-4C did not affect adenosine diphosphate (ADP)- or
collagen-induced platelet aggregation. Binding of 125I-Fab fragments of
PP3-4C to platelets was saturable at 3.7 x 10(4) +/- 0.8 x 10(4) molecules
per platelet. Another monoclonal antibody, designated PP3-3A, blocked ADP-
or collagen-induced platelet aggregation at 6 micrograms IgG/mL. At a
concentration of 10 micrograms IgG/mL, PP3-3A completely inhibited binding
either of 125I-fibrinogen or of 125I-vWF to ADP-stimulated platelets.
PP3-3A did not affect Ristocetin-induced platelet agglutination nor
125I-vWF binding to platelets in the presence of Ristocetin. Binding of
125I-Fab' fragments of PP3-3A to platelets was saturable at 9.8 x 10(4) +/-
1.2 x 10(4) molecules per platelet. PP3-4C antibody (anti-GP Ib) did not
bind to human platelets; however, PP3-3A antibody (anti-GP IIb-IIIa) had
partial cross-reactivity with human platelets. Immunoaffinity
chromatography of solubilized surface-radiolabeled porcine platelets and
subsequent sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis
demonstrated that PP3-4C recognized a GP with an apparent molecular weight
of 160,000 (nonreduced), and 140,000 (reduced). PP3-3A recognized GPs with
apparent molecular weights of 130,000 and 80,000 (nonreduced), and 115,000
and 95,000 (reduced). These monoclonal antibodies to porcine platelet
membrane GPs, which are structural and functional analogues of human GP Ib
and GP IIb/IIIa, will be useful for in vitro and in vivo studies of the
mammalian hemostatic mechanism.
Volume 72,
Issue 5,
pp. 1740-1747,
11/01/1988
Copyright © 1988 by The American Society of Hematology